Daily program
Opening presentation / Welcome speech

TBD
TBD

CHAIR: TBD
SESSION 1
TBD

Manuela Baccarini
Max Perutz Labs, University of Vienna, Vienna BioCenter, Vienna, Austria
SESSION 1
TBD

Karen Cichowski
Brigham & Women’s Hospital, Harvard Medical School, Boston, USA
SESSION 1
TBD
Short talk selected from abstracts
COFFEE BREAK

CHAIR: TBD
SESSION 2
TBD

Angeliki Malliri
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
SESSION 2
TBD

MARTIN McMAHON
Huntsman Cancer Institute, University of Utah, Salt Lake City, USA
SESSION 2
TBD
Short talk selected from abstracts
LUNCH & POSTER SESSION

CHAIR: TBD
SESSION 3
TBD

Andy Aguirre
Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA
SESSION 3
TBD

Kevin Haigis
Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA
SESSION 3
TBD
Short talk selected from abstracts
COFFEE BREAK
SESSION 4: Building a Collaborative
European Strategy on RAS (Round table)

CHAIR: TBD
SESSION 4
Round table

Moderator – Javier Carmona
VHIO, Barcelona, Spain

René Bernards
NKI, Amsterdam, The Netherlands

Chiara Ambrogio
University of Turin, Turin, Italy

FRANK McCORMICK
University of California, San Francisco, USA

TBD
(TBD)
END OF DAY 1
Place: TBD
Invited speaker´s cocktail
SESSION 5: RAS therapies (Clinical perspective)

CHAIR: TBD
SESSION 5
TBD

Alice Shaw
Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA
SESSION 5
TBD

Francesco Passiglia
Department of Oncology – University of Turin – San Luigi hospital , Orbassano (TO) – Italy
COFFEE BREAK
SESSION 6: Emerging treatments (Preclinical perspective)

CHAIR: TBD
SESSION 6
TBD

Jan Steyaert
VIB-VUB Center for Structural Biology, VIB & Vrije Universiteit Brussel, Brussels, Belgium
SESSION 6
TBD
Short talk selected from abstracts
LUNCH & POSTER SESSION
SESSION 7: Treatments to come (Industry perspective)

CHAIR: TBD
COFFEE BREAK
SESSION 8: Treatments & combinations to come
(Round table)

CHAIR: TBD
SESSION 8

Moderator – Colin Lindsay
University of Manchester and the Christie NHS Foundation Trust, Manchester, UK

Ernest Nadal
Catalan Institute of Oncology, L’Hospitalet, Spain

Alice Shaw
Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA

Kevan Shokat
University of California, San Francisco, USA

Jayesh Desai

Terri Coneran
KRAS Kickers, USA
END OF DAY 2
Place: Palacio de Figueroa
MEETING DINNER

CHAIR: TBD
SESSION 9
TBD
Short talk selected from abstracts
COFFEE BREAK

CHAIR: TBD
SESSION 10
TBD
Short talk selected from abstracts

CHAIR: TBD
END OF DAY 3

Symposium registration

Symposium registration
*Early Bird – From February 7th to August 31st.

Symposium registration
Symposium dinner
Join us for an evening of scientific dialogue and networking in a more relaxed setting. The Symposium Dinner, taking place on October 9th at 20:30, offers a unique opportunity to engage with colleagues, speakers, and industry experts in an informal yet stimulating atmosphere at Palacio de Figueroa.